Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

Analogues of botulinum toxin discovered with longer half-life

Feb. 5, 1997

Bone morphogenic protein-10 claimed by Human Genome Sciences

Feb. 5, 1997

HMR describes new cognition-enhancing agents

Feb. 5, 1997

NES-1 polypeptides reported for carcinoma detection and treatment

Feb. 5, 1997

MRI image-enhancing agents claimed by Nycomed Imaging

Feb. 5, 1997

Antineoplastic antibiotics isolated by Japanese investigators

Feb. 4, 1997

Takeda's new cephems

Feb. 4, 1997

Hoechst develops antipsychotic agents

Feb. 4, 1997

Novel diabetes treatments reported by Shaman

Feb. 4, 1997

Aminoisoindole derivatives discovered for neuropsychological disorders

Feb. 4, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 18, 2026.
ASGCT 2026: Directed evolution in gene therapy
BioWorld
Directed evolution has become a central pillar in gene therapy. This engineering strategy enables the generation of more efficient variants of genetic editors and...
ASGCT 2026: Uncovering the mechanisms of AAV toxicity
BioWorld
Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...
Fosun secures rights to Aribio’s AR-1001 in potential $4.7B deal
BioWorld
Shanghai Fosun Pharmaceutical (Group) Co. Ltd. is paying $60 million up front for an option to secure exclusive rights to Aribio Co. Ltd.’s oral phase III-stage...
Biogen AD drug shows tau, cognition benefit, despite trial miss
BioWorld
Biogen Inc. has decided to advance diranersen (BIIB-080) into registrational trials for early Alzheimer’s disease, even though the antisense oligonucleotide...